|
Product name |
Oxycodone Rapid Test Self-Test |
||||||
|
Item type |
OXY-U101 |
||||||
|
Specimens |
Urine |
||||||
|
Packing Specification |
1 kit/ box, 5 kits / box, 25 kits/ box |
||||||
|
Size |
|
||||||
|
Shelf life |
2 year |
||||||
|
Test Time |
Waiting about 5 minutes |
||||||
|
Certificate |
CE, ISO:13485 |
||||||
|
OEM |
Acceptable |
||||||
|
Service condition |
The kit should be stored at 2-30°C |
Oxycodone Rapid Test Self-Test (Colloidal Gold) is a rapid visual immunoassay method used for qualitative and inferential detection of oxycodone levels in urine. This type of testing is used to help quickly identify oxycodone drug abuse. Oxycodone Rapid Test Self-Test (Colloidal Gold) requires testing urine samples.
Oxycodone is a semi synthetic opioid drug extracted from the alkaloid Thebaine, and has been used as a potent analgesic in clinical practice for over 80 years. Due to its high bioavailability and multiple routes of administration, hydroxycodone is widely used in clinical practice. However, in clinical practice, it has been found that after high-dose continuous use of oxycodone, sudden interruption or reduction of dosage can lead to the occurrence of withdrawal syndrome in some patients. This suggests that oxycodone also has common adverse reactions to other opioid drugs. The US Food and Drug Administration (FDA) approved hydroxycodone hydrochloride controlled-release tablets in 1997 for the treatment of moderate to severe pain patients who require several days of opioid analgesics.


















